PV
Palvella Therapeutics, Inc. (PVLA)
NASDAQ·Healthcare·Biotechnology
$174.43
+11.25%
Mkt Cap $2.11B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (36 analysts)
$233.80
Range $207.00 – $270.00
Implied Upside
+34.0%
Consensus $233.80 vs current $174.43